scholarly article | Q13442814 |
P356 | DOI | 10.1002/IJC.28497 |
P8608 | Fatcat ID | release_gnw5kgqzojctjnec73a4viq6km |
P698 | PubMed publication ID | 24114735 |
P5875 | ResearchGate publication ID | 257648653 |
P50 | author | Eva Forssell-Aronsson | Q37369426 |
P2093 | author name string | Anikó Kovács | |
Per Karlsson | |||
Khalil Helou | |||
Shahin Hajizadeh | |||
Szilárd Nemes | |||
Toshima Z Parris | |||
Luaay Aziz | |||
May Semaan | |||
P2860 | cites work | Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma. | Q54424221 |
A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors. | Q54570423 | ||
The prognostic role of a gene signature from tumorigenic breast-cancer cells. | Q55042952 | ||
A functional and regulatory network associated with PIP expression in human breast cancer | Q21143857 | ||
Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis | Q24297982 | ||
Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase | Q24317284 | ||
Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 | ||
Runx2 controls a feed-forward loop between androgen and prolactin-induced protein (PIP) in stimulating T47D cell proliferation | Q28244711 | ||
The gene for prolactin-inducible protein (PIP), uniquely expressed in exocrine organs, maps to chromosome 7 | Q28276223 | ||
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer | Q28297827 | ||
Human Zn-alpha 2-glycoprotein cDNA cloning and expression analysis in benign and malignant breast tissues | Q28307345 | ||
Immunohistochemical localization of Zn-alpha 2-glycoprotein in normal human tissues | Q28308103 | ||
Supervised risk predictor of breast cancer based on intrinsic subtypes | Q29617404 | ||
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis | Q30004190 | ||
Mapping of proteins in human saliva using two-dimensional gel electrophoresis and peptide mass fingerprinting | Q30780160 | ||
Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer | Q33224305 | ||
Myeloid-related protein (MRP)-8 from cervico-vaginal secretions activates HIV replication | Q33937364 | ||
Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. | Q33976184 | ||
A Proteasome Inhibitor, Bortezomib, Inhibits Breast Cancer Growth and Reduces Osteolysis by Downregulating Metastatic Genes | Q34203659 | ||
Detection of aberrations of ubiquitin-conjugating enzyme E2C gene (UBE2C) in advanced colon cancer with liver metastases by DNA microarray and two-color FISH. | Q34537773 | ||
The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis | Q36619927 | ||
A 50-gene intrinsic subtype classifier for prognosis and prediction of benefit from adjuvant tamoxifen | Q37095809 | ||
The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes | Q38298705 | ||
Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion. | Q38498421 | ||
AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling | Q39687751 | ||
Purification and characterization of a native zinc-binding high molecular weight multiprotein complex from human seminal plasma | Q39771796 | ||
UbcH10 is overexpressed in malignant breast carcinomas | Q40068570 | ||
Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma models | Q40139853 | ||
The role of S100 genes in breast cancer progression | Q42481244 | ||
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade | Q42510471 | ||
Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes. | Q45202852 | ||
Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture--modulation by steroid hormones | Q46070543 | ||
rs4215 SNP in zinc-α2-glycoprotein gene is associated with obesity in Chinese north Han population | Q48010250 | ||
Expression of high-abundance proteins in sera of patients with endometrial and cervical cancers: analysis using 2-DE with silver staining and lectin detection methods. | Q51753225 | ||
Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. | Q53360582 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | biomarker | Q864574 |
P304 | page(s) | 1617-1629 | |
P577 | publication date | 2013-10-12 | |
P1433 | published in | International Journal of Cancer | Q332492 |
P1476 | title | Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma | |
P478 | volume | 134 |
Q37665380 | A novel molecular and clinical staging model to predict survival for patients with esophageal squamous cell carcinoma |
Q48192538 | AZGP1 inhibits soft tissue sarcoma cells invasion and migration |
Q33653747 | Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma |
Q38518851 | Context-dependent actions of Polycomb repressors in cancer |
Q51250068 | Downregulation of AZGP1 by Ikaros and histone deacetylase promotes tumor progression through the PTEN/Akt and CD44s pathways in hepatocellular carcinoma. |
Q64082786 | Downregulation of CYB5D2 is associated with breast cancer progression |
Q92582492 | Effect of STC2 gene silencing on colorectal cancer cells |
Q91329786 | Elemental Zn and its Binding Protein Zinc-α2-Glycoprotein are Elevated in HPV-Positive Oropharyngeal Squamous Cell Carcinoma |
Q41564586 | Functional proteomics outlines the complexity of breast cancer molecular subtypes. |
Q36192306 | Gene expression signature in mouse thyroid tissue after (131)I and (211)At exposure. |
Q34535960 | Gross cystic disease fluid protein-15/prolactin-inducible protein as a biomarker for keratoconus disease |
Q98778911 | Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis |
Q38857627 | Inflammation-induced S100A8 activates Id3 and promotes colorectal tumorigenesis |
Q31111254 | Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis |
Q33670486 | Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition |
Q42845103 | Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort |
Q36321995 | Overexpression of G6PD is associated with high risks of recurrent metastasis and poor progression-free survival in primary breast carcinoma |
Q34305848 | Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches |
Q90573145 | Prolactin-induced protein (PIP)-characterization and role in breast cancer progression |
Q55260675 | Protein S100-A8: A potential metastasis-associated protein for breast cancer determined via iTRAQ quantitative proteomic and clinicopathological analysis. |
Q92645325 | Reduced expression of SCUBE2 predicts poor prognosis in gastric cancer patients |
Q58709910 | Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer |
Q30978083 | The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set. |
Q42363904 | The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data |
Q41396244 | The tumor microenvironment and inflammatory breast cancer |
Q38721508 | Therapeutic vaccination based on side population cells transduced by the granulocyte-macrophage colony-stimulating factor gene elicits potent antitumor immunity. |
Q89622570 | UBE2C Overexpression Aggravates Patient Outcome by Promoting Estrogen-Dependent/Independent Cell Proliferation in Early Hormone Receptor-Positive and HER2-Negative Breast Cancer |
Q50177240 | UBE2C promotes rectal carcinoma via miR-381. |
Q31157579 | Ubiquitin-conjugating enzyme UBE2C is highly expressed in breast microcalcification lesions |
Q36223259 | Zinc-α2-Glycoprotein Exerts Antifibrotic Effects in Kidney and Heart |
Search more.